Basal intracellular cAMP levels of lymphocytes from patients with systemic sclerosis, all suffering from Raynaud's phenomenon, were significantly lower than those obtained from normal controls. Moreover, the cAMP response to isoprenaline of these patients' lymphocytes was inhibited. Intravenous infusion of prostaglandins (El and 12) restored the basal levels and greatly improved the responsiveness of the cells to isoprenaline stimulation.
Introduction
In a previous study , the low intracellular levels of cyclic adenosine 3',5'-monophosphate (cAMP) of lymphocytes measured in patients with systemic sclerosis (SS) showed a striking increase in response to isoprenaline after infusion of the patients with prostacyclin (PGI2). PGI2 infusion alone did not, however, increase the low basal lymphocyte cAMP levels. In a further attempt to monitor the observed long-term beneficial effects of infusions of prostaglandin El (PGE,) (Martin et al., 1980) and PGI2 (Dowd et al., 1982) (Boyum, 1968) . Lymphocytes (1 x 106 cells) were incubated in Hank's balanced salt solution without and with D,L-isoprenaline. Theophylline (10-2 mol/l) was added to all tubes in order to inhibit phosphodiesterase activity. cAMP was measured by radio-immunoassay, using the New England Nuclear kits.
Results
Basal levels of intracellular cAMP and the increase after isoprenaline stimulation are shown in Table 1 . In all cases, good correlation (P< 001) was found between the intracellular cAMP content and the concentration of the agonist. Basal cAMP levels of lymphocytes from SS patients were significantly lower than those from age-matched, normal controls. The cAMP response curve to isoprenaline stimulation was also significantly lower (P<0.05) than that measured in lymphocytes of normal subjects and was not parallel to it (Table 1) . In a separate study (Table   2) , PGE, infusion significantly increased the basal cAMP levels and increased cAMP response to isoprenaline stimulation. PGI2 infusion also greatly increased the basal cAMP content of the cells, resulting in a level two-or three-fold higher than the corresponding pre-treatment values. The response of ) in which we showed that lymphocyte responsiveness to isoprenaline was reduced in patients with SS. In that study, there was a tendency for basal cAMP levels to be reduced, but this was not significant. The present study now demonstrates this to a significant degree. Our findings, that both the basal cAMP levels as well as the increase in response to stimulation are significantly lower in lymphocytes from patients with SS than in cells from normal healthy subjects, can be regarded as evidence for probable altered function of these cells. Formerly, cAMP was considered as a negative regulator of the proliferative response of cells to mitogen, but recent studies have suggested a positive regulatory role of the increase in cAMP, and, in addition, endogenous prostaglandins were also thought to play an important role (Wang, Sheppard and Foden, 1978 (Inoshita et al., 1981) . In this study, peripheral blood was used which contains predominantly T lympho- 
